Panomics Integration via Machine Learning Prioritizes TAF1D as a Therapeutic Vulnerability in Lung Adenocarcinoma
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/1816649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 11.04.2026. Verfasst von Lan Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzho…. Hauptthemen laut MEDLINE: Transcription Factor TFIID, Adenocarcinoma of Lung, TATA-Binding Protein Associated Factors, Machine Learning. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is a leading cause of cancer mortality, necessitating the identification of robust biomarkers and a deeper understanding of its molecular underpinnings. This study is aimed at screening for potential LUAD biomarkers and characterizing their biological functions. Using an integrative computational framework, we combined multitranscriptomic data analysis with three machine learning algorithms (LASSO, SVM‐RFE, and random forest) to identify a consensus seven‐gene signature (TTC13, TAF1D, ZNF587, PRPF3, LINC01355, TARBP1, and CCNL2). A classifier based on this signature achieved exceptional diagnostic accuracy (AUC = 0.972), with TAF1D identified as the most influential predictor via SHAP analysis. TAF1D was significantly upregulated in tumors, correlated with an immunosuppressive microenvironment, and promoted cancer cell proliferation by regulating cell cycle and immune‐related pathways. Critically, TAF1D exhibited significant spatial heterogeneity in expression across different samples and tissue regions, suggesting it may exert region‐specific biological functions within the tumor. In conclusion, our work defines a validated gene signature for LUAD, nominating TAF1D as a key oncogenic driver and promising candidate for diagnostic and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China, hznu.edu.cn.
- Department of Nursing, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China, hznu.edu.cn.
- Geriatric Ward, The 903rd Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Hangzhou, Zhejiang, China.
- Department of General Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China, zchospital.com.
- Department of Graduate, Hangzhou Normal University, Hangzhou, Zhejiang, China, hznu.edu.cn.
ORCID-Profile: Haitao Wang, Yanyan Shi
Zitieren
APA
Ding, L., Xu, Q., Liu, D., Wu, J., Cai, X., Xu, F., Ma, S., Wang, H., & Shi, Y. (2026). Panomics Integration via Machine Learning Prioritizes TAF1D as a Therapeutic Vulnerability in Lung Adenocarcinoma. Human Mutation, 2026(1). https://doi.org/10.1155/humu/1816649
Vancouver
Ding L, Xu Q, Liu D, Wu J, Cai X, Xu F, et al. Panomics Integration via Machine Learning Prioritizes TAF1D as a Therapeutic Vulnerability in Lung Adenocarcinoma. Human Mutation. 2026;2026(1). doi:10.1155/humu/1816649
BibTeX
@article{Ding2026,
author = {Ding, Lan and Xu, Qingmei and Liu, Dongdong and Wu, Jingyu and Cai, Xufan and Xu, Feiqi and Ma, Shuhan and Wang, Haitao and Shi, Yanyan},
title = {Panomics Integration via Machine Learning Prioritizes TAF1D as a Therapeutic Vulnerability in Lung Adenocarcinoma},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/1816649}
}
EUVIMED